Inducible nitric oxide synthase enhances disease aggressiveness in pancreatic cancer

Pancreatic cancer is one of the most lethal malignancies and is refractory to the available treatments. Pancreatic ductal adenocarcinoma (PDAC) expresses high level of inducible nitric oxide synthase (NOS2), which causes sustained production of nitric oxide (NO). We tested the hypothesis that an abe...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jian, He, Peijun, Gaida, Matthias, Yang, Shouhui, Schetter, Aaron J., Gaedcke, Jochen, Ghadimi, B. Michael, Ried, Thomas, Yfantis, Harris, Lee, Dong, Weiss, Jonathan M., Stauffer, Jimmy, Hanna, Nader, Alexander, H. Richard, Hussain, S. Perwez
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5288163/
https://www.ncbi.nlm.nih.gov/pubmed/27367029
http://dx.doi.org/10.18632/oncotarget.10323

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5288163/
https://www.ncbi.nlm.nih.gov/pubmed/27367029
http://dx.doi.org/10.18632/oncotarget.10323

Ejemplares similares